货号:A155662
同义名:
秦皮乙素;二羟基香豆素
/ Cichorigenin; Aesculetin
Esculetin是一种天然的 5-脂氧合酶和 12-脂氧合酶抑制剂,IC50 值分别为 4 和 2.5 µM。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | lipoxygenase ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zileuton | ✔ | 97% | |||||||||||||||||
| Nordihydroguaiaretic acid | ✔ | 99%+ | |||||||||||||||||
| MK-886 | ✔ | 99%+ | |||||||||||||||||
| Esculetin | ✔ | 98% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Lipoxygenases are a family of iron-containing enzymes that catalyze the formation of hydroperoxides from polyunsaturated fatty acids. Esculetin is an inhibitor of both 5- and 12-lipoxygenases with ID50 values of 4 and 2.5 μM, respectively[3]. It shows inhibitory effect on platelet lipoxygenase and platelet cyclooxygenase with respective IC50 values of 0.65 and 0.45 μM[4]. Treatment of colon cancer cells with esculetin (20-80 μMol/L) for 24h effectively suppressed TOP-luciferase activity in a dose-dependent manner. In HCT116, HCT15, and DLD1 colon cancer cells, 24h- treatment of esculetin at the doses of 20 - 80 μM substantially inhibited the protein levels of c-Myc and cyclin D1, but had no effect on the expressions of β-catenin or Tcf. Consistently, the mRNA levels of c-myc and cyclin D1 in esculetin-treated human colon cancer cells was downregulated compared to control group. Moreover, esculetin at 20 - 80 μM decreased the viability of colon cancer cells, and significantly repressed anchorage-independent cell growth in a dose-dependent manner. In athymic nude mice, intraperitoneal injection of esculetin at 20 and 100 mg/kg (3 times per week) for 2 weeks suppressed HCT116 tumor size by 44% and 64%, respectively, compared to vehicle-treated group[5]. |
| Concentration | Treated Time | Description | References | |
| colonic crypt epithelium | 500 μM | 10 minutes | Completely abolished DOC-induced increases in chemiluminescence (CL) | J Clin Invest. 1986 Mar;77(3):850-9 |
| colonic mucosal scrapings | 100 μM | 10 minutes | Suppressed basal and DOC-induced increases in chemiluminescence (CL) by 40-50%, and reduced accumulation of PGE2, LTB4, 5-HETE, 12-HETE, and 15-HETE | J Clin Invest. 1986 Mar;77(3):850-9 |
| Sorted ATMs | 25 μg/mL DIL-ox-LDL | 24 hours | Esculetin significantly increased the percentage of CD36+ cells and CD36+ DIL-ox-LDL+ cells, indicating enhanced phagocytosis in ATMs. | Theranostics. 2025 Apr 28;15(12):5910-5930 |
| RAW 264.7 cells | 25 μg/mL DIL-ox-LDL | 3 to 24 hours | Esculetin significantly increased the fluorescence intensity of intracellular DIL-ox-LDL, indicating enhanced phagocytosis in macrophages. | Theranostics. 2025 Apr 28;15(12):5910-5930 |
| PC12 cells | 25 μM or 50 μM | 24 hours | Esculetin functions as an ERR agonist, enhancing glycolysis and mitochondrial respiration, leading to elevated cellular ATP levels | EBioMedicine. 2017 Aug;22:225-241 |
| Bovine chondrocytes | 31 μM–500 μM | 6 days | Esculetin inhibited IL-1-induced cartilage degradation and significantly blocked the accumulation of ADAMTS4 and MT4-MMP proteins | Osteoarthritis Cartilage. 2005 Apr;13(4):269-77 |
| T/C28a4 chondrocytes | 100–500 µM | 24 hours | To evaluate the inhibitory effect of Esculetin on MMP-1, MMP-3, and MMP-13 mRNA expression. Results showed that 250 µM EST reduced MMP-1, MMP-3, and MMP-13 mRNA expression to control levels, while TIMP-1 mRNA levels were unaffected. | Ann Rheum Dis. 2001 Feb;60(2):158-65 |
| Human articular cartilage cells | 50–500 µM | 21 days | To evaluate the inhibitory effect of Esculetin on IL1 á and OSM-induced degradation in human articular cartilage. Results showed that 50 µM EST significantly inhibited proteoglycan and collagen degradation (p<0.01) and reduced MMP-1 levels (p<0.001). | Ann Rheum Dis. 2001 Feb;60(2):158-65 |
| Bovine nasal cartilage cells | 10–330 µM | 14 days | To evaluate the inhibitory effect of Esculetin on IL1 á and OSM-induced collagen and proteoglycan degradation. Results showed that 66 µM EST significantly inhibited collagen degradation (p<0.001), and 100 µM EST significantly inhibited proteoglycan degradation (p<0.05). | Ann Rheum Dis. 2001 Feb;60(2):158-65 |
| Phytophthora sojae zoospores | 100 μM | 30 min | To evaluate the inhibitory effect of Esculetin on the chemotaxis of Phytophthora sojae zoospores. Results showed that Esculetin competitively binds to the PsIRK1 receptor, disrupting zoospore chemotaxis toward genistein and thereby inhibiting infection. | Sci Adv. 2025 Jan 10;11(2):eadt0925 |
| Administration | Dosage | Frequency | Description | References | ||
| Sprague-Dawley rats | Colonic epithelial proliferation model | Intracolonic instillation | 50 μmol (25 mM) | Single administration, observed at 4 hours (ODC activity) or 24 hours ([3H]TdR incorporation) | Inhibited DOC-induced increases in ornithine decarboxylase (ODC) activity and [3H]TdR incorporation into DNA | J Clin Invest. 1986 Mar;77(3):850-9 |
| C57BL6J male mice | High-fat diet-induced postprandial dyslipidemia model | Oral gavage | 30, 90, 180 mg/kg/d | Once daily for 7 days | Esculetin significantly elevated postprandial HDL cholesterol levels and increased bile acid content in bile, promoting cholesterol excretion. | Theranostics. 2025 Apr 28;15(12):5910-5930 |
| C57BL/6N Slc mice | MPTP-induced Parkinson's disease model | Oral | 50 mg/kg/day | 4 days per week for 5 months | Esculetin protected dopaminergic neurons by maintaining ATP levels and reducing ER stress, mitigating Parkinson's disease symptoms | EBioMedicine. 2017 Aug;22:225-241 |
| Soybean (Glycine max) | Soybean seedlings | Root dipping | 100 μM | Single treatment, lasting 30 minutes | To evaluate the preventive effect of Esculetin on Phytophthora sojae infection in soybean seedlings. Results showed that Esculetin treatment significantly increased the survival rate of soybean seedlings and reduced pathogen biomass in the roots. | Sci Adv. 2025 Jan 10;11(2):eadt0925 |
| Dose | Rat: 10 mg/kg, 50 mg/kg[3] (p.o.); 1.25 mg/kg - 20 mg/kg[4] (i.p.) Mice: 6 mg/kg[5] (p.o.) |
| Administration | p.o., i.p. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
5.61mL 1.12mL 0.56mL |
28.07mL 5.61mL 2.81mL |
56.14mL 11.23mL 5.61mL |
|
| CAS号 | 305-01-1 |
| 分子式 | C9H6O4 |
| 分子量 | 178.14 |
| SMILES Code | O=C1C=CC2=C(O1)C=C(O)C(O)=C2 |
| MDL No. | MFCD00006874 |
| 别名 | 秦皮乙素;二羟基香豆素;6,7-二羟基香豆素 ;Cichorigenin; Aesculetin; NSC 26428; CCRIS 7065; Asculetine; NSC 26427; 6,7-Dihydroxycoumarin |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
| 溶解方案 |
DMSO: 120 mg/mL(673.62 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1